Bruker Quick Ratio 2012-2026 | BRKR
Historical quick ratio values for Bruker (BRKR) over the last 10 years.
| Bruker Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2026-03-31 | $0.98B | $1.36B | 0.73 |
| 2025-12-31 | $1.12B | $1.28B | 0.87 |
| 2025-09-30 | $1.15B | $1.27B | 0.91 |
| 2025-06-30 | $0.94B | $1.35B | 0.70 |
| 2025-03-31 | $1.00B | $1.35B | 0.74 |
| 2024-12-31 | $0.99B | $1.28B | 0.77 |
| 2024-09-30 | $0.97B | $1.32B | 0.73 |
| 2024-06-30 | $0.98B | $1.31B | 0.75 |
| 2024-03-31 | $1.08B | $1.18B | 0.91 |
| 2023-12-31 | $1.20B | $1.20B | 1.00 |
| 2023-09-30 | $1.11B | $1.07B | 1.04 |
| 2023-06-30 | $1.27B | $1.05B | 1.21 |
| 2023-03-31 | $1.27B | $1.05B | 1.22 |
| 2022-12-31 | $1.31B | $0.91B | 1.44 |
| 2022-09-30 | $1.29B | $0.87B | 1.49 |
| 2022-06-30 | $1.33B | $0.82B | 1.62 |
| 2022-03-31 | $1.51B | $0.88B | 1.72 |
| 2021-12-31 | $1.76B | $0.94B | 1.88 |
| 2021-09-30 | $1.26B | $0.92B | 1.36 |
| 2021-06-30 | $1.24B | $0.96B | 1.30 |
| 2021-03-31 | $1.25B | $0.94B | 1.32 |
| 2020-12-31 | $1.23B | $0.79B | 1.56 |
| 2020-09-30 | $1.13B | $0.68B | 1.65 |
| 2020-06-30 | $1.29B | $0.75B | 1.72 |
| 2020-03-31 | $1.37B | $0.77B | 1.78 |
| 2019-12-31 | $1.22B | $0.65B | 1.89 |
| 2019-09-30 | $0.85B | $0.64B | 1.32 |
| 2019-06-30 | $0.81B | $0.64B | 1.27 |
| 2019-03-31 | $0.80B | $0.63B | 1.27 |
| 2018-12-31 | $0.80B | $0.60B | 1.33 |
| 2018-09-30 | $0.74B | $0.56B | 1.32 |
| 2018-06-30 | $0.67B | $0.53B | 1.27 |
| 2018-03-31 | $0.72B | $0.56B | 1.29 |
| 2017-12-31 | $0.87B | $0.53B | 1.66 |
| 2017-09-30 | $0.82B | $0.51B | 1.60 |
| 2017-06-30 | $0.80B | $0.49B | 1.61 |
| 2017-03-31 | $0.79B | $0.52B | 1.53 |
| 2016-12-31 | $0.84B | $0.53B | 1.59 |
| 2016-09-30 | $0.78B | $0.55B | 1.42 |
| 2016-06-30 | $0.74B | $0.54B | 1.39 |
| 2016-03-31 | $0.77B | $0.54B | 1.41 |
| 2015-12-31 | $0.81B | $0.56B | 1.46 |
| 2015-09-30 | $0.91B | $0.68B | 1.34 |
| 2015-06-30 | $0.87B | $0.65B | 1.33 |
| 2015-03-31 | $0.83B | $0.54B | 1.54 |
| 2014-12-31 | $0.89B | $0.58B | 1.53 |
| 2014-09-30 | $0.83B | $0.61B | 1.37 |
| 2014-06-30 | $0.85B | $0.63B | 1.36 |
| 2014-03-31 | $0.86B | $0.67B | 1.28 |
| 2013-12-31 | $0.84B | $0.65B | 1.30 |
| 2013-09-30 | $0.74B | $0.65B | 1.15 |
| 2013-06-30 | $0.66B | $0.60B | 1.10 |
| 2013-03-31 | $0.66B | $0.64B | 1.02 |
| 2012-12-31 | $0.70B | $0.68B | 1.02 |
| 2012-09-30 | $0.61B | $0.69B | 0.89 |
| 2012-06-30 | $0.59B | $0.75B | 0.79 |
| 2012-03-31 | $0.60B | $0.77B | 0.77 |
| 2011-12-31 | $0.62B | $0.76B | 0.82 |
| 2011-09-30 | $0.57B | $0.92B | 0.62 |
| 2011-06-30 | $0.55B | $0.90B | 0.61 |
| 2011-03-31 | $0.54B | $0.87B | 0.63 |
| 2010-12-31 | $0.54B | $0.83B | 0.65 |
| 2010-09-30 | $0.47B | $0.59B | 0.79 |
| 2010-06-30 | $0.41B | $0.54B | 0.76 |
| 2010-03-31 | $0.44B | $0.54B | 0.82 |
| 2009-12-31 | $0.45B | $0.54B | 0.83 |
| 2009-09-30 | $0.38B | $0.52B | 0.72 |
| 2009-06-30 | $0.35B | $0.52B | 0.68 |
| 2009-03-31 | $0.35B | $0.49B | 0.72 |
| 2008-12-31 | $0.40B | $0.52B | 0.76 |
| 2008-09-30 | $0.32B | $0.51B | 0.62 |
| 2008-06-30 | $0.37B | $0.58B | 0.65 |
| 2008-03-31 | $0.58B | $0.83B | 0.69 |
| 2007-12-31 | $0.59B | $0.56B | 1.05 |
| 2007-09-30 | $0.16B | $0.21B | 0.76 |
| 2007-06-30 | $0.14B | $0.19B | 0.75 |
| 2007-03-31 | $0.16B | $0.20B | 0.81 |
| 2006-12-31 | $0.16B | $0.20B | 0.82 |
| 2006-09-30 | $0.14B | $0.18B | 0.78 |
| 2006-06-30 | $0.17B | $0.12B | 1.49 |
| 2006-03-31 | $0.17B | $0.11B | 1.47 |
| 2005-12-31 | $0.20B | $0.15B | 1.34 |
| 2005-09-30 | $0.16B | $0.11B | 1.51 |
| 2005-06-30 | $0.16B | $0.10B | 1.56 |
| 2005-03-31 | $0.17B | $0.11B | 1.51 |
| 2004-12-31 | $0.16B | $0.11B | 1.47 |
| 2004-09-30 | $0.15B | $0.10B | 1.49 |
| 2004-06-30 | $0.15B | $0.10B | 1.50 |
| 2004-03-31 | $0.14B | $0.10B | 1.35 |
| 2003-12-31 | $0.14B | $0.11B | 1.29 |
| 2003-09-30 | $0.13B | $0.10B | 1.32 |
| 2003-06-30 | $0.08B | $0.07B | 1.22 |
| 2003-03-31 | $0.08B | $0.07B | 1.27 |
| 2002-12-31 | $0.16B | $0.10B | 1.60 |
| 2002-09-30 | $0.08B | $0.04B | 1.77 |
| 2002-06-30 | $0.09B | $0.05B | 1.78 |
| 2002-03-31 | $0.09B | $0.04B | 2.04 |
| 2001-12-31 | $0.09B | $0.04B | 2.32 |
| 2001-09-30 | $0.10B | $0.04B | 2.58 |
| 2001-06-30 | $0.10B | $0.04B | 2.60 |
| 2001-03-31 | $0.10B | $0.04B | 2.59 |
| 2000-12-31 | $0.11B | $0.04B | 3.14 |
| 2000-09-30 | $0.12B | $0.03B | 3.95 |
| 2000-06-30 | $0.02B | $0.04B | 0.43 |
| 2000-03-31 | $0.02B | $0.03B | 0.47 |
| 1999-12-31 | $0.02B | $0.03B | 0.55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |